- Home
- RNTX vs CPIX Comparison
RNTX vs CPIX Comparison
Compare RNTX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- CPIX
- Stock Information
- Founded
- RNTX N/A
- CPIX 1999
- Country
- RNTX United States
- CPIX United States
- Employees
- RNTX N/A
- CPIX N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- RNTX Health Care
- CPIX Health Care
- Exchange
- RNTX Nasdaq
- CPIX Nasdaq
- Market Cap
- RNTX 43.3M
- CPIX 37.9M
- IPO Year
- RNTX 2017
- CPIX 2009
- Fundamental
- Price
- RNTX N/A
- CPIX $2.53
- Analyst Decision
- RNTX
- CPIX
- Analyst Count
- RNTX 0
- CPIX 0
- Target Price
- RNTX N/A
- CPIX N/A
- AVG Volume (30 Days)
- RNTX N/A
- CPIX 509.3K
- Earning Date
- RNTX N/A
- CPIX 03-04-2025
- Dividend Yield
- RNTX N/A
- CPIX N/A
- EPS Growth
- RNTX N/A
- CPIX N/A
- EPS
- RNTX N/A
- CPIX N/A
- Revenue
- RNTX N/A
- CPIX $36,785,442.00
- Revenue This Year
- RNTX N/A
- CPIX N/A
- Revenue Next Year
- RNTX N/A
- CPIX N/A
- P/E Ratio
- RNTX N/A
- CPIX N/A
- Revenue Growth
- RNTX N/A
- CPIX N/A
- 52 Week Low
- RNTX N/A
- CPIX $1.04
- 52 Week High
- RNTX N/A
- CPIX $3.93
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- CPIX 59.45
- Support Level
- RNTX N/A
- CPIX $2.21
- Resistance Level
- RNTX N/A
- CPIX $3.93
- Average True Range (ATR)
- RNTX 0.00
- CPIX 0.33
- MACD
- RNTX 0.00
- CPIX -0.00
- Stochastic Oscillator
- RNTX 0.00
- CPIX 20.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.